Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women

被引:179
作者
Rana, JS
Mittleman, MA
Sheikh, J
Hu, FB
Manson, JE
Colditz, GA
Speizer, FE
Barr, RG
Camargo, CA
机构
[1] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[3] Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Dept Med, Boston, MA USA
[4] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA USA
[6] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Dept Med,Med Sch, Boston, MA USA
[7] Columbia Presbyterian Med Ctr, Dept Med, Div Gen Med, New York, NY USA
[8] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA USA
关键词
D O I
10.2337/diacare.27.10.2478
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Inflammation plays a key role in chronic obstructive pulmonary disease (COPD) and asthma. Increasing evidence points toward a role of inflammation in the pathogenesis of type 2 diabetes. We wanted to determine the relation of COPD and asthma with the development of type 2 diabetes. RESEARCH DESIGN AND METHODS - The Nurses' Health Study is a prospective cohort study. From 1988-1996, 103,614 female nurses were asked biennially about a physician diagnosis of emphysema, chronic bronchitis, asthma, and diabetes. RESULTS - During 8 years of follow-up, we documented a total of 2,959 new cases of type 2 diabetes. The risk of type 2 diabetes was significantly higher for patients with COPD than those without (multivariate relative risk 1.8, 95% CI 1.1-2.8). By contrast, the risk of type 2 diabetes among asthmatic patients was not increased (1.0, 0.8-1.2). The asthma results remained non-significant even when we evaluated diabetes risk by duration of asthma exposure. CONCLUSIONS - Our findings suggest that COPD may be a risk factor for developing type 2 diabetes. Differences in the inflammation and cytokine profile between COPD and asthma might explain why COPD, but not asthma, is associated with increased risk of type 2 diabetes.
引用
收藏
页码:2478 / 2484
页数:7
相关论文
共 47 条
[11]  
CREUTZBERG EC, 2004, EUR RESP J S46, V22, pS76
[12]   Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids [J].
Delaunay, F ;
Khan, A ;
Cintra, A ;
Davani, B ;
Ling, ZC ;
Andersson, A ;
Ostenson, CG ;
Gustafsson, JA ;
Efendic, S ;
Okret, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) :2094-2098
[13]   Inflammatory response and body composition in chronic obstructive pulmonary disease [J].
Eid, AA ;
Ionescu, AA ;
Nixon, LS ;
Lewis-Jenkins, V ;
Matthews, SB ;
Griffiths, TL ;
Shale, DJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (08) :1414-1418
[14]   Lung function, insulin resistance and incidence of cardiovascular disease:: a longitudinal cohort study [J].
Engström, G ;
Hedblad, B ;
Nilsson, P ;
Wollmer, P ;
Berglund, G ;
Janzon, L .
JOURNAL OF INTERNAL MEDICINE, 2003, 253 (05) :574-581
[15]   Risk of developing diabetes is inversely related to lung function:: a population-based cohort study [J].
Engström, G ;
Janzon, L .
DIABETIC MEDICINE, 2002, 19 (02) :167-170
[16]   Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study [J].
Festa, A ;
D'Agostino, R ;
Tracy, RP ;
Haffner, SM .
DIABETES, 2002, 51 (04) :1131-1137
[17]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[18]   Inflammatory status and insulin resistance [J].
Grimble, RF .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (05) :551-559
[19]   GLUCOCORTICOIDS AND THE RISK FOR INITIATION OF HYPOGLYCEMIC THERAPY [J].
GURWITZ, JH ;
BOHN, RL ;
GLYNN, RJ ;
MONANE, M ;
MOGUN, H ;
AVORN, J .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (01) :97-101
[20]  
HARRIS M, 1979, DIABETES, V28, P1039